CC BY-NC-ND 4.0 · Laryngorhinootologie 2019; 98(S 02): S363-S364
DOI: 10.1055/s-0039-1686726
Tolerability, safety and effectivity of Bevacizumab (Avastin) in hereditary hemorrhagic
teleangiectasia (HHT) – from the standard therapeutic regime to a long-term therapy
C Habekost
1
Universitätsklinikum Regensburg, Regensburg
,
K Andorfer
1
Universitätsklinikum Regensburg, Regensburg
› Author Affiliations
